Akorn (NASDAQ:AKRX) jumps 37% premarket on modest volume in apparent reaction to a Bloomberg report that several suitors, Cerberus and Vivo Capital, are exploring a bid for the generic drug maker.
https://seekingalpha.com/news/3555459-akorn-up-37-premarket-on-potential-bid
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.